Drug manufacturers Pfizer and Allergan were reported as of yesterday to be on the verge of merging into one company, with headquarters to be in Dublin, Ireland. Pfizer as much as admits that the move is to reduce its U.S. tax burden, in a move known as "tax inversion."
Ian Read, Pfizer's CEO, is reported to have claimed that the deal will "… create a leading global pharmaceutical company with the strength to research, discover and deliver more medicines and therapies to more people around the world.”
However, this is clearly going to be a very controversial move. For instance, Pfizer, a Fortune 500 company BTW, has long benefited from things like U.S. public-money support from federal agencies such as the NIH, but now they are trying to avoid taxes. However, their move is not specifically illegal, articles are saying, and it is unclear what, if anything, the U.S. government will/can do about
It is also unclear what effect this merger will have on serious questions such as research direction and, of course, its impact on drug prices, including cancer drugs.
One article, among many coming out right now, on this merger:money.cnn.com/2015/11/23/investing/pfizer-allergan-merger/
Chronic prostatitis (age 60 on)
BPH w/ urinary obstruction, 6/2011
Ongoing high PSA, 7/2011-12/2011
Biopsy, 12/2011: positive 3/12 (90%, 70%, 5%)
Gleason 6(3+3), T1c
No mets, PCa likely still organ contained
IMRT w/ HT (Lupron), 4/2012-6/2012
PSAs (since post-IMRT): 0.1 or lower